CAPR
Capricor Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +15.3% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -1 | 21.29M | $513.07M | +4 | −5 |
| Q1 2026 | 74 | +11 | 17.90M | $543.13M | +17 | −6 |
| Q4 2025 | 63 | 0 | 16.01M | $462.15M | +1 | −1 |
| Q3 2025 | 17 | +3 | 9.08M | $65.46M | +3 | — |
| Q2 2025 | 11 | +1 | 8.31M | $82.57M | +2 | −1 |
| Q1 2025 | 7 | -3 | 3.63M | $34.48M | — | −3 |
| Q4 2024 | 10 | +4 | 3.77M | $51.99M | +5 | −1 |
| Q3 2024 | 5 | -1 | 1.06M | $16.12M | +2 | −3 |
| Q2 2024 | 6 | — | 1.44M | $6.86M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.21M | — | $30.48M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 879.47K | +37.8% | $12.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 879.47K | +37.8% | $12.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 265.24K | New | $3.66M | 0.0% | New | 1 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 119.05K | +223.6% | $1.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Millennium Management ✦ | 115.64K | +22.0% | $1.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 59.30K | New | $818,381 | 0.0% | New | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 53.73K | New | $741,529 | 0.0% | New | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 40.96K | New | $565,234 | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 40.96K | New | $565,234 | 0.0% | New | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 14.24K | New | $197,000 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 11.10K | -72.0% | $153,139 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 11.10K | -72.0% | $153,139 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 11.10K | -72.0% | $153,139 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $3.66M | 0.0% |
| Marshall Wace | $818,381 | 0.0% |
| D. E. Shaw & Co. | $741,529 | 0.0% |
| Wellington Management | $565,234 | 0.0% |
| Wellington Management | $565,234 | 0.0% |
| T. Rowe Price | $197,000 | 0.0% |
Exited
| Point72 Asset Management | $3.81M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 176 holders, 33.48M shares, $1.02B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.